Acadia Pharmaceuticals (ACAD) Interest & Investment Income (2010 - 2026)

Acadia Pharmaceuticals' Interest & Investment Income history runs 4 years deep, the most recent figure standing at $41000.0 for Q1 2013.

• In Q1 2013, Interest & Investment Income rose 215.38% year-over-year to $41000.0; the TTM figure through Mar 2013 stood at $65000.0 (down 9.72% YoY), while the FY2012 annual figure was $37000.0, down 57.47% from the prior year.
• Interest & Investment Income for Q1 2013 stood at $41000.0, up from $9000.0 in the prior quarter.
• The five-year high for Interest & Investment Income was $41000.0 in Q1 2013, with the low at $5000.0 in Q3 2012.
• The 4-year median for Interest & Investment Income is $13500.0 (2011), against an average of $16666.7.
• The sharpest annual moves came in 2011 and 2012: Interest & Investment Income soared 250.0% in 2011, then plunged 70.59% in 2012.
• Acadia Pharmaceuticals' Interest & Investment Income stood at $12000.0 in 2010, then rose by 16.67% to $14000.0 in 2011, then tumbled by 35.71% to $9000.0 in 2012, then jumped by 355.56% to $41000.0 in 2013.
• Business Quant data shows ACAD's Interest & Investment Income at $41000.0 in Q1 2013, $9000.0 in Q4 2012, and $5000.0 in Q3 2012.